 | |
| Company type | Publicly traded Aktiebolag |
|---|---|
| Nasdaq Stockholm: GETI B | |
| ISIN | SE0000202624  |
| Industry | Health care |
| Founded | 1904 |
| Headquarters | Gothenburg, Sweden |
Key people | Johan Malmquist (Chairman), Mattias Perjos (President and CEO) |
| Products | Disinfectors, sterilisation equipment, surgical tables, ventilators, heart-lung machines, anesthesia, bioreactors, hospital digital integration solutions |
| Revenue | SEK 29.756 billion (2016)[1] |
| SEK 2.287 billion (2016)[1] | |
| SEK 1,213 billion (2016)[1] | |
| Total assets | SEK 55.211 billion (end 2016)[1] |
| Total equity | SEK 20.916 billion (end 2016)[1] |
Number of employees | 15582 (end 2016)[1] |
| Divisions | Getinge |
| Subsidiaries | |
| Website | getinge |
Getinge is a global medical technology company, founded in Sweden in 1904. The firm provides equipment and systems within healthcare and life sciences. The company was formerly organised in three business areas: Infection Control (trading as Getinge), Extended Care (ArjoHuntleigh) and Medical Systems (Maquet, the world's largest maker of surgical tables), but announced it would become a single brand company, operating under the brand Getinge, on 20 March 2017.[2]
In 1989, it was acquired by Rune Andersson and Carl Bennet. Getinge’s stocks have been noted on the Stockholm stock exchange since 1993 and have been part of the OMXS30 Index since July 2009.[3][4]
The company's president and CEO is Mattias Perjos. Johan Malmquist is the company's chairman. Getinge's shares have been listed on the OMX Nordic List in Stockholm since 1993 and have formed part of the OMXS30 index since July 2009.[5] In 2011 Getinge acquired the US company Atrium Medical and in 2014 Pulsion Medical Systems.[6]
